MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2026-03-31.

Cash Flow Overview

Free Cash flow
$895M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
    • Net income
    • Net change in short-term borrowi...
    • Income taxes
    • Others
Negative Cash Flow Breakdown
    • Repurchase of common stock
    • Purchase of property and equipme...
    • Accounts payable and accrued exp...
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net income
1,857 2,163 1,903 1,891
Accounts receivable
463 439 -25 -647
Inventories and other assets
-80 29 -302 67
Accounts payable and accrued expenses
-990 637 705 324
Depreciation and amortization
930 911 889 863
Income taxes
435 -1,004 434 388
Losses (gains) on sales of facilities
-1 41 -2 -3
Amortization of debt issuance costs and discounts
11 12 7 14
Share-based compensation
86 100 104 99
Other
-67 -49 -45 -48
Net cash provided by operating activities
2,014 2,359 4,416 4,210
Purchase of property and equipment
1,119 1,489 1,288 1,176
Acquisition of hospitals and health care entities
265 36 35 99
Sales of hospitals and health care entities
3 92 10 6
Change in investments
-103 -98 67 -13
Other
4 -18 8 -5
Net cash used in investing activities
-1,282 -1,317 -1,388 -1,251
Issuance of long-term debt
0 3,241 0 0
Net change in short-term borrowings and revolving credit facilities
1,435 296 138 1,548
Repayment of long-term debt
58 1,555 174 1,765
Distributions to noncontrolling interests
191 196 237 174
Payment of debt issuance costs
0 22 0 0
Payment of dividends
183 162 166 171
Repurchase of common stock
1,571 2,558 2,498 2,505
Other
-262 -43 -30 -22
Net cash used in financing activities
-830 -999 -2,967 -3,089
Effect of exchange rate changes on cash and cash equivalents
-2 0 -3 9
Change in cash and cash equivalents
-100 43 58 -121
Cash and cash equivalents at beginning of period
1,040 997 939 1,060
Cash and cash equivalents at end of period
940 1,040 997 939
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income$1,857M (1.75%↑ Y/Y)Depreciation andamortization$930M (8.14%↑ Y/Y)Income taxes$435M (-11.59%↓ Y/Y)Share-based compensation$86M (-12.24%↓ Y/Y)Inventories and other assets-$80M (-122.22%↓ Y/Y)Other-$67M (-26.42%↓ Y/Y)Amortization of debt issuancecosts and discounts$11M (0.00%↑ Y/Y)Losses (gains) on salesof facilities-$1M (-200.00%↓ Y/Y)Net cash provided byoperating activities$2,014M (21.99%↑ Y/Y)Canceled cashflow$1,453M Change in cash and cashequivalents-$100M (88.55%↑ Y/Y)Canceled cashflow$2,014M Change in investments-$103M (-267.86%↓ Y/Y)Sales of hospitals andhealth care entities$3M (-98.14%↓ Y/Y)Net change inshort-term borrowings and...$1,435M (552.27%↑ Y/Y)Accounts payable andaccrued expenses-$990M (1.00%↑ Y/Y)Accounts receivable$463M (41.59%↑ Y/Y)Net cash used ininvesting activities-$1,282M (-24.22%↓ Y/Y)Canceled cashflow$106M Net cash used infinancing activities-$830M (44.48%↑ Y/Y)Effect of exchange ratechanges on cash and cash...-$2M (-166.67%↓ Y/Y)Canceled cashflow$1,435M Purchase of property andequipment$1,119M (12.92%↑ Y/Y)Acquisition of hospitals andhealth care entities$265M (16.74%↑ Y/Y)Other$4M (33.33%↑ Y/Y)Repurchase of common stock$1,571M (-37.31%↓ Y/Y)Other-$262M (-191.11%↓ Y/Y)Distributions tononcontrolling interests$191M (-13.18%↓ Y/Y)Payment of dividends$183M (1.67%↑ Y/Y)Repayment of long-termdebt$58M (-98.51%↓ Y/Y)

2019_HCA_logo-svg

HCA Healthcare, Inc. (HCA)

2019_HCA_logo-svg

HCA Healthcare, Inc. (HCA)